1AI — Algorae Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- AU$18.58m
- AU$16.69m
- AU$0.14m
Brief: Algorae Pharmaceuticals And Zydus Enter Exclusive Commercial Agreement
Brief: Algorae Pharmaceuticals Raises A$3.9 Million At A$0.012 Per Share
Brief: Algorae Pharmaceuticals Says TGA Accepts Initial Registration Dossier For Evaluation
Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre For Second AI-Driven Drug Synergy Screening Program
Brief: Algorae Pharmaceuticals Signs License & Supply Agreement With Cadila
Brief: Algorae Pharmaceuticals Secures A$3 Million Debt Facility With Scotpac
Algorae Pharmaceuticals rises on distribution agreement with Dr Reddy's Laboratories
Brief: Algorae Pharmaceuticals Signs Distribution Agreement With Dr. Reddy's Laboratories
Brief: Algorae Pharmaceuticals Signs Binding Term Sheet With Cadila Pharmaceuticals
Australia's Algorae Pharmaceuticals rises on licensing deal with Sakar Healthcare
Brief: Algorae Pharmaceuticals Signs Exclusive License Agreement With Sakar
Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre
Australia's Algorae Pharmaceuticals gains after positive drug assessment
Brief: Algorae Pharmaceuticals Says Cessation Of Co's American Depositary Share Deposit Agreement
Brief: Algorae Pharmaceuticals Says First Version Of Algoraeos AI Platform On Schedule And Anticipated By Q3 Of 2024
Brief: Algorae Pharmaceuticals Provides NTCELL Project Update
Brief: Algorae Pharmaceuticals Says Agreement With Hl Pharma
Brief: Algorae Pharmaceuticals Executed Deal With University Of New South Wales
Australia's Living Cell Tech jumps on Parkinson's disease trail progress